{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:21:40Z","timestamp":1789993300173,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.intimp.2018.05.010","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T16:48:50Z","timestamp":1526921330000},"page":"8-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Renoprotective effect of the isoflavonoid biochanin A against cisplatin induced acute kidney injury in mice: Effect on inflammatory burden and p53 apoptosis"],"prefix":"10.1016","volume":"61","author":[{"given":"Faiha A.","family":"Suliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina M.","family":"Khodeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"Ibrahiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman T.","family":"Mehanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.","family":"El-Kherbetawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala M.F.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan A.","family":"Zaitone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser M.","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"34","key":"10.1016\/j.intimp.2018.05.010_bb0005","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0959-8049(98)00224-X","article-title":"Clinical development of platinum complexes in cancer therapy: an historical perspective and an update","volume":"1990","author":"Lebwohl","year":"1998","journal-title":"Eur. J. Cancer Oxf. Engl."},{"key":"10.1016\/j.intimp.2018.05.010_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(19850515)55:10<2303::AID-CNCR2820551002>3.0.CO;2-L","article-title":"Fundamental studies with cisplatin","volume":"55","author":"Rosenberg","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2018.05.010_bb0015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/bi00324a025","article-title":"Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation","volume":"24","author":"Fichtinger-Schepman","year":"1985","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.intimp.2018.05.010_bb0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/bi981854n","article-title":"Single d(GpG)\/cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization","volume":"38","author":"Suo","year":"1999","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.intimp.2018.05.010_bb0025","doi-asserted-by":"crossref","first-page":"10772","DOI":"10.1073\/pnas.89.22.10772","article-title":"An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts","volume":"89","author":"Szymkowski","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2018.05.010_bb0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2210-4-20","article-title":"Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats","volume":"4","author":"Chirino","year":"2004","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0035","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0272-6386(86)80112-3","article-title":"Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity","volume":"8","author":"Ries","year":"1986","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.intimp.2018.05.010_bb0040","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","article-title":"Cisplatin nephrotoxicity","volume":"23","author":"Arany","year":"2003","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0045","first-page":"151","article-title":"Cisplatin nephrotoxicity: symptomatic hypomagnesemia and renal failure","volume":"7","author":"Gomez Campdera","year":"1986","journal-title":"Int. J. Pediatr. Nephrol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0050","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO;2-N","article-title":"The renal pathology in clinical trials of cis-platinum (II) diamminedichloride","volume":"39","author":"Gonzales-Vitale","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2018.05.010_bb0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1523-1755.1998.00767.x","article-title":"In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity","volume":"53","author":"Baliga","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2018.05.010_bb0060","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.V12122683","article-title":"Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide","volume":"12","author":"Davis","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0065","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2018.05.010_bb0070","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1046\/j.1523-1755.1999.00629.x","article-title":"Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody","volume":"56","author":"Kelly","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2018.05.010_bb0075","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.biocel.2012.04.021","article-title":"Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging","volume":"44","author":"Chapple","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0080","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.redox.2013.07.005","article-title":"Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-\u03baB pathways in diabetic neuropathy","volume":"1","author":"Ganesh Yerra","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0085","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cellsig.2011.01.014","article-title":"Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway","volume":"23","author":"Yu","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2018.05.010_bb0090","doi-asserted-by":"crossref","first-page":"15244","DOI":"10.1074\/jbc.M113.540633","article-title":"Transcription factors NRF2 and NF-\u03baB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation","volume":"289","author":"Cuadrado","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2018.05.010_bb0095","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1038\/sj.onc.1206949","article-title":"The role of p53 in chemosensitivity and radiosensitivity","volume":"22","author":"El-Deiry","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2018.05.010_bb0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2018.05.010_bb0105","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/sj.onc.1208615","article-title":"The p53 pathway: positive and negative feedback loops","volume":"24","author":"Harris","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2018.05.010_bb0110","first-page":"7316","article-title":"Tissue-specific induction of p53 targets in vivo","volume":"62","author":"Fei","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2018.05.010_bb0115","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1038\/sj.onc.1209440","article-title":"Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis","volume":"25","author":"Jiang","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2018.05.010_bb0120","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0091-3057(03)00116-3","article-title":"Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones","volume":"75","author":"Duffy","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.intimp.2018.05.010_bb0125","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1021\/acs.jafc.7b00967","article-title":"Potential lipid-lowering mechanisms of biochanin A","volume":"65","author":"Xue","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.intimp.2018.05.010_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-008-9714-8","article-title":"Chemoprevention of mammary tumorigenesis and chemomodulation of the antioxidative enzymes and peroxidative damage in prepubertal Sprague Dawley rats by biochanin A","volume":"312","author":"Mishra","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2018.05.010_bb0135","first-page":"217","article-title":"Biochanin A ameliorates the cytokine secretion profile of lipopolysaccharide-stimulated macrophages by a PPAR\u03b3-dependent pathway","volume":"5","author":"Qiu","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2018.05.010_bb0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neulet.2006.11.045","article-title":"Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation","volume":"417","author":"Chen","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.intimp.2018.05.010_bb0145","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1515\/znc-2007-11-1210","article-title":"Screening of various phenolic acids and flavonoid derivatives for their anticholinesterase potential","volume":"62","author":"Orhan","year":"2007","journal-title":"Z. Naturforsch., C: J. Biosci."},{"key":"10.1016\/j.intimp.2018.05.010_bb0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/biof.5520120137","article-title":"Attenuation of neurodegeneration-relevant modifications of brain proteins by dietary soy","volume":"12","author":"Kim","year":"2000","journal-title":"BioFactors Oxf. Engl."},{"key":"10.1016\/j.intimp.2018.05.010_bb0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/0960327113497772","article-title":"Biochanin-A ameliorates behavioural and neurochemical derangements in cognitive-deficit mice for the betterment of Alzheimer's disease","volume":"33","author":"Biradar","year":"2014","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2011.11.051","article-title":"Antihyperglycemic effect of biochanin a, a soy isoflavone, on streptozotocin-diabetic rats","volume":"676","author":"Harini","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2006.06.011","article-title":"Ascorbic acid and \u03b1-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study","volume":"375","author":"Ajith","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2018.05.010_bb0170","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/clpt.2009.139","article-title":"Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity","volume":"86","author":"Filipski","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2018.05.010_bb0175","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1046\/j.1523-1755.2003.00908.x","article-title":"Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis","volume":"63","author":"Liu","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2018.05.010_bb0180","first-page":"195","article-title":"Effect of pentoxifylline against doxorubicin-induced nephrotoxicity in rabbits","volume":"30","author":"Al-Saedi","year":"2015","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.intimp.2018.05.010_bb0185","first-page":"4","article-title":"Review of qualification data for biomarkers of nephrotoxicity submitted by the predictive safety testing consortium","author":"Blank","year":"2009"},{"key":"10.1016\/j.intimp.2018.05.010_bb0190","doi-asserted-by":"crossref","first-page":"F700","DOI":"10.1152\/ajprenal.1996.270.4.F700","article-title":"Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis","volume":"270","author":"Lieberthal","year":"1996","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-2143(98)90060-9","article-title":"The role of oxygen free radicals in cisplatin-induced acute renal failure in rats","volume":"131","author":"Matsushima","year":"1998","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.intimp.2018.05.010_bb0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jgr.2016.03.001","article-title":"Preventive effect of fermented black ginseng against cisplatin-induced nephrotoxicity in rats","volume":"41","author":"Jung","year":"2017","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.intimp.2018.05.010_bb0205","first-page":"146","article-title":"Effects of nifedipine on cisplatinum-induced nephrotoxicity in rats","volume":"30","author":"Deray","year":"1988","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0210","first-page":"1269","article-title":"Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum-(II) in rats","volume":"39","author":"Pera","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2018.05.010_bb0215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.urolonc.2011.01.019","article-title":"The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosis","volume":"31","author":"Szliszka","year":"2013","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"10.1016\/j.intimp.2018.05.010_bb0220","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s002040050444","article-title":"Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats","volume":"71","author":"Appenroth","year":"1997","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0225","first-page":"397","article-title":"Acute and chronic cisplatin nephropathy in rats","volume":"44","author":"Choie","year":"1981","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.ki.5002256","article-title":"The pathological role of Bax in cisplatin nephrotoxicity","volume":"72","author":"Wei","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2018.05.010_bb0235","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/ndt\/12.12.2478","article-title":"Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application","volume":"12","author":"Kuhlmann","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2018.05.010_bb0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.intimp.2018.05.010_bb0245","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/bjc.1996.673","article-title":"Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity","volume":"74","author":"Bokemeyer","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2018.05.010_bb0250","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ki.1985.101","article-title":"Course of acute renal failure studied by a model of creatinine kinetics","volume":"27","author":"Mark Moran","year":"1985","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2018.05.010_bb0255","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.lfs.2011.06.016","article-title":"Glycyrrhizic acid: a phytochemical with a protective role against cisplatin-induced genotoxicity and nephrotoxicity","volume":"89","author":"Arjumand","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2018.05.010_bb0260","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3892\/or.2014.2996","article-title":"ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression and ameliorate cisplatin-induced nephrotoxicity","volume":"31","author":"Wei","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2018.05.010_bb0265","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1172\/JCI200215606","article-title":"TNF-\u03b1 mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity","volume":"110","author":"Ramesh","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2018.05.010_bb0270","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/ndt\/gfp242","article-title":"Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation","volume":"24","author":"Kang","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2018.05.010_bb0275","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ki.2008.409","article-title":"Genistein protects the kidney from cisplatin-induced injury","volume":"74","author":"Sung","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2018.05.010_bb0280","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2009.03.024","article-title":"Telmisartan, an angiotensin II type 1 receptor antagonist, attenuates T-type Ca2+ channel expression in neonatal rat cardiomyocytes","volume":"609","author":"Morishima","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0290","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.atherosclerosis.2005.08.009","article-title":"Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice","volume":"186","author":"Takaya","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2018.05.010_bb0295","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/labinvest.2008.75","article-title":"The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis","volume":"88","author":"Xu","year":"2008","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0300","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2009.08.156","article-title":"Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems","volume":"389","author":"Okada","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2018.05.010_bb0305","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.intimp.2016.06.009","article-title":"Biochanin A protects lipopolysaccharide\/d-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation","volume":"38","author":"Liu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0310","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0006-2952(99)00303-2","article-title":"Role of apoptosis in cisplatin-induced toxicity in the renal epithelial cell line LLC-PK1","volume":"59","author":"Okuda","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0315","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000046116","article-title":"Role of ginsenoside-Rd in cisplatin-induced renal injury: special reference to DNA fragmentation","volume":"89","author":"Yokozawa","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.intimp.2018.05.010_bb0320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00204-003-0521-4","article-title":"Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney","volume":"78","author":"Sheikh-Hamad","year":"2004","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0325","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1089\/152308602762197452","article-title":"Apoptotic pathways of oxidative damage to renal tubular epithelial cells","volume":"4","author":"Basnakian","year":"2002","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2018.05.010_bb0330","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.cdd.4401817","article-title":"Cellular response to endoplasmic reticulum stress: a matter of life or death","volume":"13","author":"Boyce","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2018.05.010_bb0335","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.intimp.2018.05.010_bb0340","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.biochem.69.1.217","article-title":"Apoptosis signaling","volume":"69","author":"Strasser","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.intimp.2018.05.010_bb0345","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2018.05.010_bb0350","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.302.1.8","article-title":"Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways","volume":"302","author":"Cummings","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2018.05.010_bb0355","doi-asserted-by":"crossref","first-page":"F1282","DOI":"10.1152\/ajprenal.00230.2007","article-title":"Activation and involvement of p53 in cisplatin-induced nephrotoxicity, AJP","volume":"293","author":"Wei","year":"2007","journal-title":"Ren. Physiol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0360","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.bcp.2007.01.010","article-title":"Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity","volume":"73","author":"Jiang","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2018.05.010_bb0365","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1523\/JNEUROSCI.0155-04.2004","article-title":"Nuclear factor-B modulates the p53 response in neurons exposed to DNA damage","volume":"24","author":"Aleyasin","year":"2004","journal-title":"J. Neurosci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918302212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918302212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T23:39:59Z","timestamp":1661297999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918302212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":73,"alternative-id":["S1567576918302212"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.05.010","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renoprotective effect of the isoflavonoid biochanin A against cisplatin induced acute kidney injury in mice: Effect on inflammatory burden and p53 apoptosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}